KA/EN
Register
Medicines reference
Search
Search
Product

Minipress

Favourites

Prazosin · Pfizer

3 forms: tablet. No registration in force in Georgia.

Forms and doses0 of 3 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Used for: Functional urethral obstruction

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
1 mg, Tablet · Cat Cat 0.25–0.5 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (iCatCare consensus 2025), same substance and route. Urethral spasm / functional obstruction: 0.25-0.5 mg per cat; a trial found no fewer re-obstructions after urethral obstruction; watch for hypotension.
 · once daily		 once daily Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 1მგ აბი - #50
Verified on: 29 Oct 2026
1 mg, Tablet · Dog Dog 0.5–3 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (ACVIM consensus 2024), same substance and route. Functional urethral obstruction: 0.5-3 mg per dog; start low, watch for hypotension, weakness or syncope.
 · every 8-12 hours		 every 8-12 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 1მგ აბი - #50
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Minipress 1 mg, Tablet

tablet, human medicine
Composition / strength
Prazosin1 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Pfizer · United States
Registration
Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 1მგ აბი - #50
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
0.25–0.5 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (iCatCare consensus 2025), same substance and route. Urethral spasm / functional obstruction: 0.25-0.5 mg per cat; a trial found no fewer re-obstructions after urethral obstruction; watch for hypotension.
 Cat Any weight By mouth once daily
iCatCare LUTD consensus 2025
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats
Journal of Feline Medicine and Surgery, 2025
From the active substance's dose: the label does not cover this species; off-label for this pack.
0.5–3 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (ACVIM consensus 2024), same substance and route. Functional urethral obstruction: 0.5-3 mg per dog; start low, watch for hypotension, weakness or syncope.
 Dog Any weight By mouth every 8-12 hours
ACVIM urinary incontinence
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs
Journal of Veterinary Internal Medicine, 2024
From the active substance's dose: the label does not cover this species; off-label for this pack.
2 mg, Tablet · Cat Cat 0.25–0.5 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (iCatCare consensus 2025), same substance and route. Urethral spasm / functional obstruction: 0.25-0.5 mg per cat; a trial found no fewer re-obstructions after urethral obstruction; watch for hypotension.
 · once daily		 once daily Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 2მგ აბი - #30
Verified on: 29 Oct 2026
2 mg, Tablet · Dog Dog 0.5–3 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (ACVIM consensus 2024), same substance and route. Functional urethral obstruction: 0.5-3 mg per dog; start low, watch for hypotension, weakness or syncope.
 · every 8-12 hours		 every 8-12 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 2მგ აბი - #30
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Minipress 2 mg, Tablet

tablet, human medicine
Composition / strength
Prazosin2 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Pfizer · United States
Registration
Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 2მგ აბი - #30
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
0.25–0.5 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (iCatCare consensus 2025), same substance and route. Urethral spasm / functional obstruction: 0.25-0.5 mg per cat; a trial found no fewer re-obstructions after urethral obstruction; watch for hypotension.
 Cat Any weight By mouth once daily
iCatCare LUTD consensus 2025
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats
Journal of Feline Medicine and Surgery, 2025
From the active substance's dose: the label does not cover this species; off-label for this pack.
0.5–3 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (ACVIM consensus 2024), same substance and route. Functional urethral obstruction: 0.5-3 mg per dog; start low, watch for hypotension, weakness or syncope.
 Dog Any weight By mouth every 8-12 hours
ACVIM urinary incontinence
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs
Journal of Veterinary Internal Medicine, 2024
From the active substance's dose: the label does not cover this species; off-label for this pack.
5 mg, Tablet · Cat Cat 0.25–0.5 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (iCatCare consensus 2025), same substance and route. Urethral spasm / functional obstruction: 0.25-0.5 mg per cat; a trial found no fewer re-obstructions after urethral obstruction; watch for hypotension. The 1 mg tablet suits cats better: this dose is a tenth to a twentieth of a 5 mg tablet.
 · once daily		 once daily Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 5მგ აბი - #50
Verified on: 29 Oct 2026
5 mg, Tablet · Dog Dog 0.5–3 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (ACVIM consensus 2024), same substance and route. Functional urethral obstruction: 0.5-3 mg per dog; start low, watch for hypotension, weakness or syncope.
 · every 8-12 hours		 every 8-12 hours Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 5მგ აბი - #50
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Minipress 5 mg, Tablet

tablet, human medicine
Composition / strength
Prazosin5 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Pfizer · United States
Registration
Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: მინიპრესი 5მგ აბი - #50
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
0.25–0.5 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (iCatCare consensus 2025), same substance and route. Urethral spasm / functional obstruction: 0.25-0.5 mg per cat; a trial found no fewer re-obstructions after urethral obstruction; watch for hypotension. The 1 mg tablet suits cats better: this dose is a tenth to a twentieth of a 5 mg tablet.
 Cat Any weight By mouth once daily
iCatCare LUTD consensus 2025
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats
Journal of Feline Medicine and Surgery, 2025
From the active substance's dose: the label does not cover this species; off-label for this pack.
0.5–3 mg per animal
Off-label substance bridge: a human Prazosin product; dose from Core prazosin (ACVIM consensus 2024), same substance and route. Functional urethral obstruction: 0.5-3 mg per dog; start low, watch for hypotension, weakness or syncope.
 Dog Any weight By mouth every 8-12 hours
ACVIM urinary incontinence
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs
Journal of Veterinary Internal Medicine, 2024
From the active substance's dose: the label does not cover this species; off-label for this pack.

Known Contraindications

  • Warning
    Alpha-1 blocker: hypotension, weakness, syncope and GI upset can occur; start at the low end and watch for weakness or collapse, more so with other antihypertensives or sedatives.
    Sources: ACVIM
  • Warning
    Alpha-1 blocker: hypotension, weakness, syncope and GI upset can occur; start at the low end and watch for weakness or collapse, more so with other antihypertensives or sedatives.
    Sources: ACVIM

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 29 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗